Ladenburg Thalmann Financial Services’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$95K Sell
819
-23
-3% -$2.78K ﹤0.01% 3047
2019
Q3
$106K Buy
842
+98
+13% +$12.4K ﹤0.01% 2895
2019
Q2
$89K Sell
744
-1,769
-70% -$174K ﹤0.01% 3050
2019
Q1
$221K Buy
2,513
+1,698
+208% +$154K ﹤0.01% 2319
2018
Q4
$81K Buy
815
+193
+31% +$20.3K ﹤0.01% 2909
2018
Q3
$72K Sell
622
-465
-43% -$48.1K ﹤0.01% 3078
2018
Q2
$79K Hold
1,087
﹤0.01% 2917
2018
Q1
$79K Buy
1,087
+28
+3% +$1.92K ﹤0.01% 2917
2017
Q4
$61K Buy
1,059
+143
+16% +$7.53K ﹤0.01% 3083
2017
Q3
$41K Sell
916
-37
-4% -$1.54K ﹤0.01% 3226
2017
Q2
$38K Buy
953
+209
+28% +$8.58K ﹤0.01% 3203
2017
Q1
$30K Buy
744
+400
+116% +$15.6K ﹤0.01% 3274
2016
Q4
$14K Sell
344
-54
-14% -$2.04K ﹤0.01% 3692
2016
Q3
$14K Buy
398
+106
+36% +$3.64K ﹤0.01% 3618
2016
Q2
$8K Sell
292
-856
-75% -$25.9K ﹤0.01% 3887
2016
Q1
$40K Buy
1,148
+390
+51% +$12.6K ﹤0.01% 2752
2015
Q4
$24K Buy
758
+126
+20% +$4.09K ﹤0.01% 3086
2015
Q3
$20K Buy
632
+275
+77% +$10.3K ﹤0.01% 3100
2015
Q2
$15K Sell
357
-270
-43% -$11.4K ﹤0.01% 3417
2015
Q1
$28K Buy
627
+77
+14% +$3.22K ﹤0.01% 2969
2014
Q4
$21K Sell
550
-62
-10% -$2.27K ﹤0.01% 2950
2014
Q3
$21K Buy
612
+108
+21% +$3.85K ﹤0.01% 2625
2014
Q2
$18K Sell
504
-78
-13% -$2.61K ﹤0.01% 2734
2014
Q1
$19K Hold
582
﹤0.01% 2608
2013
Q4
$25K Sell
582
-120
-17% -$4.94K ﹤0.01% 2392
2013
Q3
$28K Buy
702
+120
+21% +$5.04K ﹤0.01% 2226
2013
Q2
$24K Buy
+582
New +$23.6K ﹤0.01% 2213

Other funds holding HAE

Ladenburg Thalmann Financial Services's HAE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Haemonetics (HAE) stake by 2.7% in Q4 2019, selling an estimated $2.78K and leaving 819 shares worth $95K. The position accounts for ﹤0.01% of the portfolio, ranked #3047.

Ladenburg Thalmann Financial Services first reported a position in HAE in Q2 2013 and has held it in 27 quarters since. The position peaked at $221K in Q1 2019. 298 funds tracked by Wall St. Rank hold HAE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 819 shares of Haemonetics worth $95K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 23 Haemonetics shares in Q4 2019, an estimated $2.78K.
  • Haemonetics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3047 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Haemonetics in Q2 2013 and has held it in 27 quarters since.
  • Ladenburg Thalmann Financial Services's Haemonetics position peaked at $221K in Q1 2019.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.